Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines

Heterologous “prime-boost” regimens that involve priming with plasmid DNA vaccines and boosting with recombinant viral vectors have been shown to elicit potent virus-specific cytotoxic T-lymphocyte responses. Increasing evidence, however, suggests that the utility of recombinant viral vectors in hum...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Barouch, Dan H., McKay, Paul F., Sumida, Shawn M., Santra, Sampa, Jackson, Shawn S., Gorgone, Darci A., Lifton, Michelle A., Chakrabarti, Bimal K., Xu, Ling, Nabel, Gary J., Letvin, Norman L.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2003
Matèries:	Vaccines and Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC167238/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12885892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.16.8729-8735.2003
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!